| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9202 |
| Human Intestinal Absorption | HIA+ | 0.9601 |
| Caco-2 Permeability | Caco2+ | 0.6673 |
| P-glycoprotein Substrate | Non-substrate | 0.5187 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8592 |
| Non-inhibitor | 0.8913 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8509 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9027 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8016 |
| CYP450 2D6 Substrate | Non-substrate | 0.8944 |
| CYP450 3A4 Substrate | Non-substrate | 0.6466 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7190 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8402 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8810 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7771 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8724 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8916 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9177 |
| Non-inhibitor | 0.7812 |
| AMES Toxicity | Non AMES toxic | 0.9632 |
| Carcinogens | Non-carcinogens | 0.8455 |
| Fish Toxicity | High FHMT | 0.9869 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9999 |
| Honey Bee Toxicity | Low HBT | 0.5000 |
| Biodegradation | Ready biodegradable | 0.8880 |
| Acute Oral Toxicity | III | 0.7958 |
| Carcinogenicity (Three-class) | Non-required | 0.5920 |